Last edition
News about "Wockhardt USA LLC"
Wockhardt Q1 Loss Widens to INR 108 Crore on US Subsidiary Liquidation
The loss was mainly driven by a INR 97 crore goodwill impairment following the company’s permanent exit from the US generics market and the voluntary liquidation of its Delaware-based subsidiaries, Morton Grove Pharmaceuticals Inc. and Wockhardt USA LLC.
Wockhardt USA LLC | 11/08/2025 | By Darshana
Wockhardt Realigns US Operations to Focus on Innovative Portfolio, Exits Generic Pharma Segment
Wockhardt has announced a strategic realignment of its US operations, exiting the loss-making generics business to focus on its innovation-led priorities in novel antibiotics and biologics, marking a decisive shift toward building a differentiated, future-ready pharmaceutical enterprise.
Wockhardt USA LLC | 11/07/2025 | By Mrinmoy Dey | 134
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy